_the-latest-lung-cancer-research-updates-from-asco-2022.jpg "The Latest Lung Cancer Research Updates From ASCO 2022 from immunotherapy in cancer Video Screenshot Preview")
GalleryPlay Video:
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
⏲ Duration: 1 min 80 sec
✓ Published: 14-Sep-2022
✓ Published: 14-Sep-2022
Description:
Dr. Tejas Patil from the University of Colorado Cancer Center shares the latest news in lung cancer research and treatment from the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting, including an update on immunotherapy. nnDr. Tejas Patil is an academic thoracic oncologist at the University of Colorado Cancer Center focused on targeted therapies and novel biomarkers in lung cancer. Learn more about Dr. Patil, here: http://cudoctors.com/Find_A_Doctor/Profile/24489.
Dr. Tejas Patil from the University of Colorado Cancer Center shares the latest news in lung cancer research and treatment from the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting, including an update on immunotherapy. nnDr. Tejas Patil is an academic thoracic oncologist at the University of Colorado Cancer Center focused on targeted therapies and novel biomarkers in lung cancer. Learn more about Dr. Patil, here: http://cudoctors.com/Find_A_Doctor/Profile/24489.
Share with your friends:
Whatsapp | Viber | Telegram | Line | SMS
Email | Twitter | Reddit | Tumblr | Pinterest
Related Videos
_immunotherapy-clinical-trial-for-gbm.webp "Cure Brain Cancer Foundation is helping to fund this clinical trial, which will see Australian researchers joining forces with global counterparts to evaluate the effectiveness of an immunotherapy called durvalumab (MEDI4736) in patients with GBM.")
_how-does-immunotherapy-treat-myeloma.webp "Immunotherapy harnesses one’s own immune system to fight cancer. Dr. Krina Patel, a myeloma specialist and researcher, explains how this therapy changing the treatment landscape for myeloma.nnDr. Krina Patel is an Associate Professor in the Department of Lymphoma/Myeloma at The University of Texas MD Anderson Cancer Center in Houston, Texas. Dr. Patel is involved in research and cares for patients with multiple myeloma. Learn more about Dr. Patel https://faculty.mdanderson.org/profiles/krina_p")
_parker-foundation-film-1-cancer-immunotherapy.webp "Over three years ago, we had the pleasure of working with the Parker Foundation on three animations. They aired at an event hosted by the one and only Tom Hanks in LA.Each film took a different look at the war on cancer.nnThis film is a brief overview on cancer. We see how treatments used to fight cancer affect our bodies, and how immunotherapy can provide an alternate attack against this beast.nnCancer is no laughing matter, but we tried to have some fun with it.nnWe had an amazing team that")
_dr-ben-carson-on-the-potential-behind-galectin-therapeutics.webp "Ben Carson: Interestingly enough, I was spending some time at the Uline headquarters, and I was so intrigued by the fact that the CEO, Dick Uihlein, who has no medical background, was so fascinated with Galectin Therapeutics and what they could potentially do that caused me to start looking into it, and really seeing that some of the possibilities of being able to inhibit things like the deleterious protein complex like galectin-3, which is significant in so many types of pathologies, things lik")
_lung-cancer-treatment-approaches-what-are-your-options.webp "How is lung cancer treated? Dr. Jessica Bauman provides an overview of lung cancer treatment modalities, including surgery, radiation and systemic therapies such as chemotherapy, immunotherapy, and targeted therapy. nnDr. Jessica Bauman is assistant professor in the department of hematology/oncology and as associate program director of the hematology/oncology fellowship training program at Fox Chase Cancer Center in Philadelphia. Learn more about Dr. Bauman here: https://www.foxchase.org/jessica")
_2009-career-achievement-medal-recipient.webp "For more than five decades, Dr. Thomas Waldmann has performed cutting-edge science at the National Institutes of Health, resulting in great advances in treatment for patients with multiple sclerosis, various types of cancer and AIDS.nnDescribed by his peers as a “renaissance scientist,” Waldmann’s work extends from the study of the immune system to innovative clinical trials of immunotherapeutic agents, which help your immune system perform better. Cancer immunotherapy, for example, helps")
_why-choose-medical-oncology-trainee-perspective.webp "Dr Shanthini Crusz (Barts Cancer Institute, London, UK), Dr Sarah Duncan (Royal Free Hospital, London, UK), Dr Steve Kihara (Loughborough University, Loughborough, UK), Dr Anna Olsson-Brown (The Clatterbridge Cancer Centre & The University of Liverpool, Liverpool, UK), Dr Jonathan Lim (The Christie NHS Foundation Trust, Manchester, UK), Dr Emily Goode (Royal Marsden and ICR, London, UK) and Dr Edward Armstrong (Royal Marsden Hospital, London, UK) spoke with ecancer at the ACP immun")
_esmo-e-learning-first-line-immunotherapy-for-oesophageal-and-gastric-cancer-as-new-standard-of-care.webp "ESMO e-Learning: First Line Immunotherapy for Oesophageal and Gastric Cancer as New Standard of Care from immunotherapy in cancer")
ESMO e-Learning: First Line Immunotherapy for Oesophageal and Gastric Cancer as New Standard of Care
⏲ 16 min 93 sec ✓ 02-Jun-2022
_immunotherapy-clinical-trial-for-gbm.jpg)
_how-does-immunotherapy-treat-myeloma.jpg)
_parker-foundation-film-1-cancer-immunotherapy.jpg)
_dr-ben-carson-on-the-potential-behind-galectin-therapeutics.jpg)
_lung-cancer-treatment-approaches-what-are-your-options.jpg)
_2009-career-achievement-medal-recipient.jpg)
_why-choose-medical-oncology-trainee-perspective.jpg)
_esmo-e-learning-first-line-immunotherapy-for-oesophageal-and-gastric-cancer-as-new-standard-of-care.jpg)
![[+]](/images/menu.gif){kind=small}